ArgusEye develops sensor systems utilizing nanoplasmonic sensing and fiber optics for real-time monitoring of biological processes. Their technology enables in-line analysis, enhancing efficiency in bioprocessing by providing immediate data on critical quality attributes.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current bioprocessing workflows rely on offline analytics, which delays feedback loops and hinders real-time optimization of critical quality attributes. Traditional methods lack the ability to continuously monitor and control biological systems, limiting efficiency in biologics development and production.
Solution
ArgusEye provides innovative sensor systems for real-time monitoring and analysis of biological systems and processes. Their patented technology utilizes nanoplasmonic sensing combined with fiber optics to enable in-line analysis. The Auga platform delivers specific, real-time data, previously confined to off-line analytics, to transform how biologics are developed and produced. The system enhances chromatography with in-line data, improving downstream process efficiency with integrated sensor systems providing essential real-time data.
Target Audience
The primary target audience includes professionals in the bioprocessing industry, specifically those involved in biologics development and production, and researchers in related fields.
Features
- Nanoplasmonic sensing combined with fiber optics for real-time monitoring.
- In-line analysis capabilities, enabling immediate data acquisition.
- Customizable receptors for flexible and sensitive sensing of various targets.
- AugaOne™ platform for enhanced chromatography with real-time data integration.
- Integrated sensor systems for downstream bioprocessing.
- Continuous monitoring of important quality attributes and process parameters.